PISA, Italy and HONG KONG, Sept. 8, 2014 /CNW/ - Abiogen Pharma S.p.A. and Lee's Pharmaceutical Holdings Limited jointly announced the agreement for License, Distribution and Supply for marketing of Thorens® Cholecalciferol (or vitamin D3) throughout China, Hong Kong, Macau and Taiwan.
Under the terms of this agreement, Abiogen granted Lee's an exclusive license and right for registering, importing, marketing, distributing and selling the Cholecalciferol finished products (oral drops, oral solution and solution for injection), for the prevention and treatment of vitamin D deficiency.
Dr. Massimo Di Martino, President & CEO of Abiogen said: "I am very pleased to extend our strategic collaboration to valorize Lee's capacities in Hong Kong, China and other countries. Deficiency of vitamin D is a Global Silent Epidemic. We have the means to address this threat and we should start in the most populated countries of the world."
"We are excited to expand our partnership with Abiogen in this important area of bone metabolism," said Dr. Benjamin Li, CEO of Lee's. "Vitamin D deficiency is a growing problem, especially in patients on dialysis. The availability of Cholecalciferol will certainly strengthen Lee's' presence in the dialysis area where the Group's leading product has been helping the improvement of quality of life of dialysis patients."
About Abiogen Pharma
Abiogen Pharma is a specialist pharmaceutical company focused on bone metabolism and some rare diseases. The Company was founded in 1997 in Pisa, Italy. Since the first registration in Italy in 2005, Abiogen Pharma is recognized as a reference in vitamin D market with Dibase® (Italy) and Thorens® (international). Both are leading prescription medicines that naturally restore vitamin D levels, thanks to the physiological mode of action of cholecalciferol. According to IMS HEALTH, since 2012 Abiogen Pharma is the world leader in Cholecalciferol sales in terms of value.
About Lee's Pharmaceutical
Lee's Pharmaceutical Holdings Limited is a research-based Hong Kong biopharmaceutical company with 20 years operation in China's pharmaceutical industry.
Cholecalciferol is a natural compound synthesized by the skin under strong summer sun and utilized by the human body on a need basis. It is now regarded as an essential molecule with hormone-like activities coordinating various physiological functions, in addition to its classical activity in bone mineralization process. Its deficiency may cause serious life- threatening conditions, if left untreated. The most efficient way to replenish the reservoirs and maintain normal vitamin D values in man is to supplement Vitamin D exogenously.
SOURCE: Abiogen Pharma
For further information: Mithu Sen, Tel: +39-(0)50-3154-273, Email: [email protected]